Japan Cardiovascular Ultrasound Market Size, Share, and COVID-19 Impact Analysis, By Type (Fetal Echocardiography, Transthoracic Echocardiography, Transesophageal Echocardiography, and Others), By Technology (2D, 3D/4D, and Doppler), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers, and Other End-uses), and Japan Cardiovascular Ultrasound Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI13561
PAGES 215
REPORT FORMAT PathSoft

Japan Cardiovascular Ultrasound Market Insights Forecasts to 2035

  • The Japan Cardiovascular Ultrasound Market Size Was Estimated at USD 178.7 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 5.52% from 2025 to 2035
  • The Japan Cardiovascular Ultrasound Market Size is Expected to Reach USD 322.6 Million by 2035

Japan Cardiovascular Ultrasound Market

Get more details on this report -

Request Free Sample PDF

The Japan Cardiovascular Ultrasound Market Size is anticipated to Reach USD 322.6 Million by 2035, Growing at a CAGR of 5.52% from 2025 to 2035. The Japan Cardiovascular Ultrasound Market Size is expanding due to increased cases of cardiovascular disease, an aging population, and technological advances in portable ultrasound technology. Growing rates of coronary artery disease and stroke, as well as elderly patients preference for minimally invasive diagnostics, are major demand drivers.

 

Market Overview

The Japan Cardiovascular Ultrasound Market Size refers to imaging technologies that utilize sound waves to evaluate heart structure, function, and blood flow. It is extensively applied in the diagnosis of heart diseases, treatment monitoring, and the guidance of minimally invasive interventions in hospitals as well as outpatient facilities. Strengths lie in advanced R&D, the presence of domestic champions such as Canon, Fujifilm, Hitachi, and an established healthcare infrastructure. Opportunities include AI driven imaging, 3D or 4D and contrast echo systems, telehealth, and remote monitoring integration. It is driven by Japans demographic aging, increasing prevalence of cardiovascular disease, and growing need for portable testing diagnostics. Government policy, preventive healthcare campaigns, increased reimbursement under universal healthcare, and backing of digital health are driving adoption. Furthermore, investment in less invasive and wearable cardiac monitoring and telemedicine infrastructure holds rapid potential.

 

Report Coverage

This research report categorizes the market for the Japan cardiovascular ultrasound market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan cardiovascular ultrasound market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub segment of the Japan cardiovascular ultrasound market.

 

Japan Cardiovascular Ultrasound Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 178.7 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :CAGR of 5.52%
2035 Value Projection:USD 322.6 Million
Historical Data for:2020-2023
No. of Pages:215
Tables, Charts & Figures:94
Segments covered:By Type, By End-use
Companies covered::FUJIFILM Healthcare Corporation, Hitachi Ltd., Canon Medical Systems Corporation, GE Healthcare Japan Corporation, Siemens Healthineers AG, Samsung Medison, Koninklijke Philips N.V., Nipro Corporation, HOLOGIC JAPAN, INC., Chison Medical Imaging, Terumo Corporation, Esaote SPA, and Other Key Companies.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The Japan market for cardiovascular ultrasound is fueled by an increasingly aging population, the growing incidence of cardiovascular disease, and a demand for early, non invasive diagnosis. The development of portable and AI enabled ultrasound machines, along with powerful homegrown players such as Canon and Fujifilm, further accelerates adoption. Government incentives via healthcare reform, reimbursement schemes, and preventive care plans also drive growth in the market. Furthermore, increasing demand for telemedicine and remote monitoring technologies is increasing the application of cardiovascular ultrasound in Japans healthcare system.

 

Restraining Factors

The high equipment costs, low reimbursement levels, and lack of skilled operators, particularly in rural settings, are issues confronting the Japan cardiovascular ultrasound market. Adoption is also limited by strict regulatory approval processes and competition from other imaging modalities such as CT and MRI.

 

Market Segmentation

The Japan cardiovascular ultrasound market share is classified into type, technology, and end use.  

 

  • The transthoracic echocardiography segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cardiovascular ultrasound market is segmented by type into fetal echocardiography, transthoracic echocardiography, transesophageal echocardiography, and others. Among these, the transthoracic echocardiography segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to its widespread use as the first line non invasive cardiac evaluation tool is attributed to its capacity for quick evaluation of ventricular function, valvular disease, and hemodynamics. Clinical guidelines always endorse their application for successful diagnosis in both outpatient and inpatient populations.

 

  • The 2D segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cardiovascular ultrasound market is segmented by technology into 2D, 3D/4D, and doppler. Among these, the 2D segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to providing a balance of cost, operational simplicity, and clinical utility in everyday cardiovascular evaluation. Its incorporation into screening, diagnosis, and monitoring paradigms propels its use. Vendors augment 2D systems with functionality such as harmonic imaging and speckle tracking, increasing diagnostic confidence without excessive cost or eliminating limitations for broad clinical acceptance.

 

  • The hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cardiovascular ultrasound market is segmented by end use into hospitals, diagnostic centers, ambulatory care centers, and other end uses. Among these, the hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to their sophisticated diagnostic facilities, access to experienced cardiologists, and capacity for high volume patient management. Their complex cardiac interventions also make hospitals the site of choice for cardiovascular ultrasound imaging in Japan.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan cardiovascular ultrasound market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • FUJIFILM Healthcare Corporation
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • GE Healthcare Japan Corporation
  • Siemens Healthineers AG
  • Samsung Medison
  • Koninklijke Philips N.V.
  • Nipro Corporation
  • HOLOGIC JAPAN, INC.
  • Chison Medical Imaging
  • Terumo Corporation
  • Esaote SPA
  • Others

 

Recent Developments:

  • In July 2023, Canon Medical launched its compact ultrasound systems, Aplio Flex and Aplio go, designed to support healthcare professionals. Aplio Go offers agile, reliable imaging with a small footprint, while Aplio Flex delivers mobile, high efficiency performance with advanced imaging and intelligent, automated workflow features.

 

Key Target Audience

  • Market Players
  • Investors
  • End users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan cardiovascular ultrasound market based on the below mentioned segments:

 

Japan Cardiovascular Ultrasound Market, By Type

  • Fetal Echocardiography
  • Transthoracic Echocardiography
  • Transesophageal Echocardiography
  • Others

 

Japan Cardiovascular Ultrasound Market, By Technology

  • 2D
  • 3D/4D
  • Doppler

 

Japan Cardiovascular Ultrasound Market, By End use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Other End uses

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies